Skip to content

Anxiety: all studies

Page 580 of 769: studies 5,791 to 5,800 of 7,689, newest first. Back to the anxiety overview

Research

N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine

Human Psychopharmacology: Clinical and Experimental February 17, 2022 Edward James, Joachim Keppler, Ben Sessa et al. 41 citations

Abstract Objective Reports have indicated possible uses of ayahuasca for the treatment of conditions including depression, addictions, post‐traumatic stress disorder, anxiety and specific psychoneuroendocrine immune system pathologies. The article assesses potential ayahuasca and N,N‐dimethyltryptamine (DMT) integration with contemporary healthcare. The review also seeks to provide a summary of...

Factors influencing mindfulness among clinical nurses in China: An observational cross‐sectional study

Journal of Nursing Management February 16, 2022 Junye Yu, Yuanyuan Song, Hua Dan et al. 15 citations

AIM: The aim of this study was to evaluate factors influencing mindfulness among clinical nurses in China. BACKGROUND: Mindfulness has positive effects on nurses' negative emotions and job burnout. However, few studies have explored the antecedent variables of mindfulness. METHODS: A total of 358 clinical nurses in Beijing Aerospace Center Hospital completed a cross-sectional survey between...

'Mindfulness Living with Insomnia': an mHealth intervention for individuals with insomnia in China: a study protocol of a randomised controlled trial.

BMJ Open February 15, 2022 Chen Pan, Bingyu Tie, Weichao Yuwen et al.

Introduction: Insomnia has a remarkably negative effect on the work, quality of life and psychosomatic health of individuals, and imposes a substantial economic burden on society. Mindfulness-based interventions (MBIs) have proven beneficial in the treatment of insomnia. However, the effect of mobile or online-based (mHealth) MBIs requires further verification. This study will evaluate the...

Real-world patient characteristics, treatment patterns, efficacy and safety of intramuscular ketamine treatment: a retrospective cohort study

Research Square February 14, 2022 Sachin Ahuja, Madeline Brendle, Leo Smart et al. 2 citations preprint

Abstract Background Ketamine has emerged as a promising pharmacotherapy for depression and other mental illnesses, and the intramuscular (IM) administration of ketamine is now offered at many North American outpatient psychiatric clinics. However, a characterization of the outpatient population receiving IM ketamine treatment, and an evaluation of the real-world efficacy and safety of long-term...

Teaching meditation to college students within an historical and cultural context: A qualitative analysis of undergraduate reflections on contemplative practice

Current Psychology February 12, 2022 Sylvia Sensiper

There is a growing interest in contemplative practices in higher education. Researchers have explored the use of meditation to address the increasing requests for counseling and as a resource for improving student mental health. Contemplative practices have also been incorporated into the fundamental learning objectives in some US universities. This study of teaching methods uses first-person...

Is approving esketamine as an antidepressant for treatment resistant depression associated with recreational use and risk perception of ketamine? Results from a longitudinal and cross-sectional survey in nightlife attendees.

International Journal of Drug Policy February 9, 2022 Meryem Grabski, Jon Waldron, Tom P. Freeman et al.

BACKGROUND Esketamine was licensed for use in treatment resistant depression by the European Medicines Agency in December 2019. It is unclear whether this new approval has lowered the risk perception of recreational ketamine use. This is important given a recent increase in recreational ketamine use. METHODS This study expanded on an existing longitudinal online study of the nightlife scene, by...

Stay mindfully active during the coronavirus pandemic: a feasibility study of mHealth-delivered mindfulness yoga program for people with Parkinson's disease.

BMC Complementary Medicine and Therapies February 7, 2022 Jojo Yan Yan Kwok, Jung Jae Lee, Edmond Pui Hang Choi et al.

Importance: Patients with long-term neurological conditions, such as Parkinson's disease (PD), are particularly vulnerable to the public health measures taken to combat the COVID-19 pandemic. The inaccessibility of center-based rehabilitation further aggravated their motor dysfunctions as well as mental distress, leading to exacerbation of motor and non-motor symptoms, high healthcare...

DOI: 10.1186/s12906-022-03519-y (opens in new tab) Full text (opens in new tab) Mindfulness Humans Parkinson disease Gait disorders, neurologic +17

Epidemic Dreams: Dreaming about health during the COVID-19 pandemic

arXiv Preprint Archive February 2, 2022 Sanja Šćepanović, Luca Maria Aiello, Deirdre Barrett et al. preprint

The continuity hypothesis of dreams suggests that the content of dreams is continuous with the dreamer's waking experiences. Given the unprecedented nature of the experiences during COVID-19, we studied the continuity hypothesis in the context of the pandemic. We implemented a deep-learning algorithm that can extract mentions of medical conditions from text and applied it to two datasets...

Full text (opens in new tab) Cs.si Cs.cl Cs.cy

An online non-meditative mindfulness intervention for people with ALS and their caregivers: a randomized controlled trial.

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration February 2022 Francesco Pagnini, Deborah Phillips, Anne Haulman et al.

Objectives: Mindfulness-based interventions seem to be effective in promoting QOL of ALS patients and caregivers, but most require substantial time. In the Langerian approach, mindfulness can be easily promoted with mental tasks and short lectures. This study aims to explore the impact of an ALS-specific online Langerian mindfulness training program on QOL of ALS patients. Methods: We developed...

DOI: 10.1080/21678421.2021.1928707 (opens in new tab) Full text (opens in new tab) Mindfulness Amyotrophic lateral sclerosis Caregivers Psychological intervention +1

Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects.

Psychophysiology February 2022 Elisa Pabon, Frederica Rockwood, Greg J Norman et al.

Cannabis is the most commonly used psychotropic drug in the United States, after alcohol. Despite its apparent sedative and calming effects, cannabis and its main psychoactive constituent, ∆9 -tetrahydrocannabinol (THC) can produce serious adverse effects including tachycardia and anxiety. These effects can be especially pronounced in women, who remain underrepresented in clinical cannabinoid...

DOI: 10.1111/psyp.13955 (opens in new tab) Full text (opens in new tab) Cannabis Autonomic Delta-9-tetrahydrocannabinol Heart rate variability +1